Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts.

Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Abstract Text:

    brad j spellbergBrad J Spellberg,mary collinsMary Collins,valentina avanesianValentina Avanesian,mayela gomezMayela Gomez,john e edwardsJohn E Edwards,christopher cogleChristopher Cogle,david applebaumDavid Applebaum,yue fuYue Fu,ashraf s ibrahimAshraf S Ibrahim,

    Although granulocyte transfusion is a logical, therapeutic option for neutropenic patients with refractory infections, significant technical barriers have prevented its widespread use. A novel phagocyte transfusion strategy has been developed based on activation of a human myeloid cell line HL-60. To further define the potential for HL-60 cells to recapitulate white cell transfusions, a shortened duration of activation was evaluated, facile quality control markers were defined, and the impact of low-dose irradiation on cell function was determined. Three days of activation resulted in increased cell viability and in vitro candidacidal capacity but with slightly higher cell replication compared with 7 days of activation. Cell viability and several flow cytometric measurements were accurate, quality control markers for HL-60 activation. In combination with activation, low-dose irradiation abrogated replication while sparing the candidacidal effects of the HL-60 cells. Infusion of irradiated, activated HL-60 cells improved survival of neutropenic, candidemic mice significantly. In summary, activated, irradiated HL-60 cells are microbicidal, have virtually no replicative capacity, and are safe and effective at protecting neutropenic mice against an otherwise 100% fatal candidal infection. With continued development, this strategy to recapitulate neutrophil functions has the potential to serve as an effective alternative to granulocyte transfusions.

    Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Publishing Authors By Initials

    bj spellbergBJ Spellberg,m collinsM Collins,v avanesianV Avanesian,m gomezM Gomez,je edwardsJE Edwards,c cogleC Cogle,d applebaumD Applebaum,y fuY Fu,as ibrahimAS Ibrahim,

    For similar surgical procedures, operative: transplantation: transplantation, heterologous research abstracts see: surgical procedures, operative: transplantation: transplantation, heterologous research

    PUBMED ID PMID:

    MEDLINE DATE:

    Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of leukocyte biology

    VOLUME: 81

    Page Numbers: 632-41

    Journal Abbreviation: J. Leukoc. Biol.

    ISSN: 0741-5400

    DAY: 8

    MONTH: 12

    YEAR: 2006

    Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8405628

    Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Keywords Mesh Terms:

    KEYWORDS: Transplantation, Heterologous

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts.

    AFFILIATION: Division of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA. bspellberg@labiomed.org

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: R03 AI054531

    ACRONYM: AI

    MEDLINETA: J Leukoc Biol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News